307 related articles for article (PubMed ID: 26799963)
1. Reversing neuromuscular blockade: inhibitors of the acetylcholinesterase versus the encapsulating agents sugammadex and calabadion.
Haerter F; Eikermann M
Expert Opin Pharmacother; 2016; 17(6):819-33. PubMed ID: 26799963
[TBL] [Abstract][Full Text] [Related]
2. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
[TBL] [Abstract][Full Text] [Related]
4. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Successful Reversal of Residual Block with Sugammadex in a Patient Not Known to Have Myasthenia Gravis.
Kuo KC; Wong CS; Wu TJ
Am J Case Rep; 2022 Oct; 23():e937128. PubMed ID: 36229945
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents.
Haerter F; Simons JC; Foerster U; Moreno Duarte I; Diaz-Gil D; Ganapati S; Eikermann-Haerter K; Ayata C; Zhang B; Blobner M; Isaacs L; Eikermann M
Anesthesiology; 2015 Dec; 123(6):1337-49. PubMed ID: 26418697
[TBL] [Abstract][Full Text] [Related]
7. Reversal of neuromuscular block in companion animals.
Jones RS; Auer U; Mosing M
Vet Anaesth Analg; 2015 Sep; 42(5):455-71. PubMed ID: 26058553
[TBL] [Abstract][Full Text] [Related]
8. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
9. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
[TBL] [Abstract][Full Text] [Related]
10. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
de Menezes CC; Peceguini LA; Silva ED; Simões CM
Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
Togioka BM; Schenning KJ
Drugs Aging; 2022 Oct; 39(10):749-761. PubMed ID: 35934764
[TBL] [Abstract][Full Text] [Related]
12. Preparing for the unexpected: special considerations and complications after sugammadex administration.
Iwasaki H; Renew JR; Kunisawa T; Brull SJ
BMC Anesthesiol; 2017 Oct; 17(1):140. PubMed ID: 29041919
[TBL] [Abstract][Full Text] [Related]
13. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
Meistelman C; Donati F
Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
[TBL] [Abstract][Full Text] [Related]
14. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
15. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
16. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
17. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
19. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
20. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
